TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR
conference contribution
posted on 2022-11-23, 03:22authored byDean Popovski, Catherine Cochrane, Elizabeth Algar, Anette Szczepny, Samantha Jayasekara, David Ashley, Peter Downie, Neil Watkins, Jason Cain
TARGETED CATALYTIC INHIBITION OF EZH2 SYNERGIZES WITH LOW-DOSE PANOBINOSTAT IN MALIGNANT RHABDOID TUMOR